COVID-19 testing has evolved significantly since the pandemic's early days. Today, two main test types — rapid antigen tests and PCR (polymerase chain reaction) tests — give people fast, accessible ways to determine whether they're infected. Rapid antigen tests, available over-the-counter at pharmacies and online, deliver results in 15 minutes from a simple nasal swab. PCR tests, processed in laboratories, take hours to days but offer higher sensitivity. Knowing when to use each, how to interpret results, and what to do based on those results helps you make better decisions about isolation, exposure to others, and seeking treatment.

Rapid antigen tests detect viral proteins (antigens) on the surface of the SARS-CoV-2 virus. They're less sensitive than PCR — meaning they may produce a negative result early in infection when viral levels are low — but they're highly specific, meaning a positive result reliably indicates infection. The trade-off is well-suited to many practical scenarios: testing before gatherings, confirming infection when you have symptoms, or monitoring during the contagious period to determine when isolation can end.

PCR tests detect viral genetic material (RNA) and are sensitive enough to identify infection earlier than antigen tests, sometimes before you become contagious. They're the gold standard for clinical diagnosis but require specialized lab equipment, qualified personnel, and processing time that ranges from hours at hospital labs to days at high-volume commercial labs. PCR tests cost more and require visiting a testing site or providing a sample for shipping, making them less convenient for routine self-testing.

This guide covers the major COVID test types, how each works, when to use which, how to interpret results, and the practical implications of positive or negative findings. Whether you're testing because you have symptoms, were exposed to someone with COVID, or want to confirm you're safe to attend an event, you'll find clear information here for making informed decisions.

The variety of rapid antigen test brands creates a challenge for consumers — different brands have slightly different performance characteristics. The FDA maintains a list of authorized at-home tests on its website with sensitivity and specificity data for each. Brands like BinaxNOW, iHealth, Flowflex, and BD Veritor are widely used and have published performance data from regulatory studies. Brand-name tests have proven track records; deeply discounted unbranded tests sometimes lack the same regulatory rigor. When choosing tests, sticking with FDA-authorized brands provides reasonable assurance of performance.

Rapid antigen tests work through a process called lateral flow immunoassay. You collect a nasal sample with the included swab, mix it with a buffer solution, and apply drops to the test cassette. As the liquid wicks across the test strip, antibodies on the strip bind to viral antigens (if present) and produce a colored line in the test region. A control line confirms the test ran correctly. Results appear within 15 to 30 minutes depending on the brand. Common over-the-counter brands include BinaxNOW, iHealth, Flowflex, and BD Veritor.

Sample collection technique matters significantly for rapid antigen test accuracy. Most kits direct you to swab the lower part of each nostril (about 0.5-1 inch deep) for 5-15 seconds, rotating the swab against the nasal walls. Going too shallow misses the area where viral particles concentrate. Going too deep is uncomfortable but doesn't improve results. Following the kit's specific instructions precisely produces the most accurate result. Reading the test outside the recommended time window is a common error — too early misses developing positives; too late may produce false positives from drying.

PCR testing requires more elaborate sample collection — typically a healthcare provider performs a deeper nasal swab (nasopharyngeal swab) at a testing facility. The sample is sealed in transport medium and shipped to a lab. There, technicians extract viral RNA, amplify it through cycles of heating and cooling with specific reagents, and detect the amplified product. Modern PCR machines complete this process in 1-2 hours, though commercial labs handling thousands of samples may take 24-72 hours to deliver results to patients due to logistics rather than analysis time.

For most people considering routine medical testing options for COVID, rapid antigen tests are sufficient. They're appropriate for screening before social gatherings, monitoring after known exposure, and confirming COVID when symptoms appear. PCR tests are appropriate when antigen tests are negative but symptoms strongly suggest COVID, when high-stakes decisions depend on a definitive answer (preoperative testing, immunocompromised patient evaluation), or when public health surveillance requires precise documentation of cases.

Both tests have specific time windows when they perform best. Rapid antigen tests are most accurate during peak viral load, typically days 2-5 of symptomatic infection. Testing too early (day 1 of symptoms) may produce false negatives because viral levels haven't yet reached detection threshold. PCR tests detect virus earlier — sometimes 1-2 days before symptoms develop — and remain positive longer, occasionally for weeks after infection clears (without indicating active contagion). Like a blood test, timing affects what the result means.

Storage conditions affect rapid antigen test reliability. The chemicals on the test strips degrade with heat, moisture, or freezing. A test stored in a hot car all summer may give unreliable results regardless of unopened packaging. Tests stored according to package directions (typically room temperature, dry, away from sunlight) and used before expiration date perform within their stated accuracy ranges. Check expiration dates before testing — many people store unused tests for months or years and forget to verify they're still valid before relying on results.

Reading rapid antigen test results follows a consistent pattern across brands. Two lines (one in the control region and one in the test region) indicate a positive result. One line in the control region only indicates a negative result. No control line means an invalid test — discard it and use a fresh kit. The test line in a positive result may be faint, especially during early or late infection. Faint lines that appear within the reading window are still positive — any visible color in the test region indicates detected antigen.

False negatives are the most common testing problem. They happen when viral load is too low to detect — typically very early in infection (day 1 of symptoms) or after the contagious period has ended but symptoms persist. The CDC and FDA recommend repeat testing 48 hours after a negative result if symptoms continue or strong exposure is suspected. Serial testing dramatically improves overall sensitivity — three antigen tests over six days approaches PCR-level reliability for identifying infections.

False positives are uncommon but possible. Reading tests outside the specified time window is the leading cause — drying samples can produce faint lines that aren't true positives. Taking another test from a different brand can resolve uncertainty. Some studies have found that certain medical conditions, recent COVID vaccinations, or contamination of testing surfaces can rarely produce false positives, but these are uncommon. A clearly positive antigen test (strong test line, within reading window, control line present) is reliable confirmation of infection in nearly all cases.

What you do after a positive test depends on your situation. CDC current guidance recommends 5 days of isolation from symptom onset (or test date if asymptomatic) followed by 5 additional days of mask-wearing in public. Symptoms can be managed with rest, hydration, fever reducers, and over-the-counter cough suppressants. Antiviral treatments like Paxlovid are most effective when started within 5 days of symptom onset for high-risk patients. Contacting your healthcare provider promptly after a positive test enables consideration of antiviral options if appropriate for your risk profile.

Insurance coverage for COVID testing has shifted significantly. During the public health emergency, most tests were free; now coverage varies. Most insurance plans cover medically necessary PCR testing ordered by a provider. Some cover at-home antigen tests purchased OTC, often via reimbursement after submitting receipts. The number of free tests provided by the federal government through covidtests.gov has fluctuated over time. Verifying current coverage with your insurer before testing helps avoid unexpected costs, especially for higher-priced PCR or rapid PCR options.

The relationship between viral load, contagiousness, and test results matters for understanding why tests can sometimes seem to give conflicting signals. Tests positive when viral load exceeds the detection threshold; you're contagious when your viral load is high enough to spread infection. These thresholds aren't identical — sometimes test-positive individuals don't transmit much (very early infection); sometimes test-negative individuals do transmit (very late infection or with antigen tests of lower sensitivity). Understanding this nuance helps explain why testing alone isn't perfect protection but remains a valuable tool when combined with other measures.

Symptoms of COVID continue to evolve as new variants emerge, but the most common ones remain fairly consistent: fever, cough, fatigue, sore throat, body aches, headache, and respiratory symptoms ranging from congestion to shortness of breath. Loss of taste or smell, which was distinctive in early Omicron and earlier variants, has become less common with newer variants. Gastrointestinal symptoms (nausea, diarrhea) appear in some patients. Severe symptoms — chest pain, severe shortness of breath, persistent confusion, blue-tinged lips — warrant emergency evaluation regardless of test results.

For people with mild illness, home management is usually sufficient. Rest, fluids, fever reducers (acetaminophen or ibuprofen), and over-the-counter cold medications address most symptoms. Avoid aspirin in patients under 18 due to Reye's syndrome risk. Stay home and isolate from household members when possible to limit spread. Most people recover fully within 1-2 weeks, though fatigue and lingering symptoms can persist longer in some cases (post-acute COVID, sometimes called "long COVID").

For high-risk patients — those over 65, immunocompromised, with chronic conditions like diabetes, heart disease, or lung disease — antiviral treatment can significantly reduce risk of severe disease. Paxlovid (nirmatrelvir/ritonavir) is most commonly prescribed; it's most effective when started within 5 days of symptom onset. Remdesivir is an IV alternative for hospitalized patients. The decision to prescribe antivirals is made by a healthcare provider based on individual risk factors and contraindications. Even mildly symptomatic high-risk patients should contact their provider promptly after a positive test to discuss options.

Avoiding COVID transmission through testing is most effective when combined with other measures. Even highly accurate testing has gaps — false negatives happen, viral loads vary, and timing matters. Layering protection — vaccination, masking in higher-risk settings, ventilation when indoors with others, distancing when possible — reduces transmission risk more reliably than testing alone. The pregnancy test example shows how single-purpose tests work; COVID tests fit the same pattern, providing useful information about a specific question rather than comprehensive protection by themselves.

Pediatric COVID testing presents unique considerations. Most rapid antigen tests are FDA-authorized for children as young as 2 years old, though sample collection (nasal swab) can be challenging and cause distress. Some pediatricians offer professional sample collection that's more reliable than parent-administered home tests. PCR testing requires deeper swabs that are harder to perform on young children. School-age children typically tolerate testing better, especially with familiar caregivers performing the swab and clear explanations of what's happening and why.

The future of COVID testing continues to develop. Combination tests that detect COVID, flu, and RSV simultaneously have appeared on the market, helping people identify which respiratory infection they have without separate tests for each. PCR-quality testing in even smaller, faster, cheaper formats is in development, potentially bringing lab-grade sensitivity to home use within a few years. The technological direction generally favors more sensitive, faster, more accessible testing — the question is how widely insurance coverage and pricing will support routine use.

Workplace and school testing programs that emerged during the pandemic have largely wound down, but selective testing requirements remain in some healthcare and educational settings. Testing requirements for international travel similarly have diminished but still exist for some destinations. Checking specific requirements before travel, employment, or returning to school in healthcare or congregate living settings remains important for affected populations.

Long COVID has become an important consideration in the post-acute period after infection. Symptoms persisting more than 4 weeks after acute infection — fatigue, brain fog, shortness of breath, sleep problems, chest pain — affect a meaningful percentage of people who had even mild COVID. While there's no specific test for long COVID, monitoring your recovery and reporting persistent symptoms to your healthcare provider helps with management. Long COVID research continues; treatment approaches are evolving.

Beyond individual decisions about testing, public health surveillance of COVID continues through wastewater monitoring, hospital-based reporting, and selective community testing studies. These programs track viral spread at population scale, which informs CDC guidance and individual decision-making. Community transmission data from your local health department can help guide your personal protection strategies, especially during periods of higher community spread.

Workplace and gathering decisions around COVID testing have become more nuanced as the public health emergency phase has ended. Some workplaces still maintain testing requirements for symptomatic employees or following known exposures; others have moved to symptom-only screening. Personal hosts of gatherings sometimes ask attendees to test before arrival, especially when vulnerable individuals will be present. Communicating testing expectations clearly in advance — both for hosts and attendees — helps everyone make informed decisions about participation and protective measures during shared events.